Circulating Th22 and Th9 levels in patients with acute coronary syndrome. - Wikidata - wikimedia - TriplyDB

Circulating Th22 and Th9 levels in patients with acute coronary syndrome.

Circulating Th22 and Th9 levels in patients with acute coronary syndrome.

http://www.wikidata.org/entity/Q37449413

about

Inflammation in arterial diseases Dual opposing roles of adaptive immunity in hypertension.IL-22-producing Th22 cells play a protective role in CVB3-induced chronic myocarditis and dilated cardiomyopathy by inhibiting myocardial fibrosis MicroRNA and transcription factor mediated regulatory network analysis reveals critical regulators and regulatory modules in myocardial infarction Inflammation Enhances the Risks of Stroke and Death in Chronic Chagas Disease Patients.Elevated plasma levels of Th17-related cytokines are associated with increased risk of atrial fibrillation Interleukin-22 Might Act as a Double-Edged Sword in Type 2 Diabetes and Coronary Artery Disease.Novel Biomarker MicroRNAs for Subtyping of Acute Coronary Syndrome: A Bioinformatics Approach.Serum Cytokine Profile in Relation to the Severity of Coronary Artery Disease.Increased Th9 cells and IL-9 levels accelerate disease progression in experimental atherosclerosis.Th22 cell is a gradually proved potential biomarker for acute coronary syndrome.Impact of adalimumab treatment on cardiovascular risk biomarkers in psoriasis: Results of a pilot study.Circulating Th1, Th2, Th9, Th17, Th22, and Treg Levels in Aortic Dissection Patients

P2860

Q26853576-6701BA70-E55D-4E2B-8C2D-C8E5E1B4BB73 Q33606181-505B5465-1878-4255-B0DA-E134DC9F9D5C Q35005069-3D7C6916-545D-4FBF-BBF4-186762074407 Q35741348-160F72C8-BA1C-4394-A6AB-34BECEC8CDC5 Q35999538-50C10252-3EF6-4879-990C-6576DD1AACA9 Q36919277-D517717A-C2E4-4E65-AC9D-21A7E54F2CDC Q37382631-665E76FA-0FD4-4917-B957-819D0C95402F Q37503986-AEECADC9-9BE6-4ECA-B197-C8C96461E782 Q37703419-BC90E767-87B3-4C13-A737-A054E6043017 Q37733033-6268A722-1D26-4C0F-9AB2-CCD97E848679 Q39963064-DE236EA6-B5C6-46B7-96F7-26B83A7E92D8 Q51367320-CB81536C-B27B-4B40-A2E7-DC5B81B9C0F4 Q58761186-05A363D6-37FD-4EC8-B1B9-9BD5BC6ADB18

P2860

Circulating Th22 and Th9 levels in patients with acute coronary syndrome.

http://www.wikidata.org/entity/Q37449413

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 23 December 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Circulating Th22 and Th9 levels in patients with acute coronary syndrome.

@en

Circulating Th22 and Th9 levels in patients with acute coronary syndrome.

@nl

type

label

Circulating Th22 and Th9 levels in patients with acute coronary syndrome.

@en

Circulating Th22 and Th9 levels in patients with acute coronary syndrome.

@nl

prefLabel

Circulating Th22 and Th9 levels in patients with acute coronary syndrome.

@en

Circulating Th22 and Th9 levels in patients with acute coronary syndrome.

@nl

P1433

Q37449413-C8CEC3D1-1F8E-489A-A6E4-CC488D6A8972

P1476

Q37449413-977A0FD5-66F3-4270-8EF5-12624758E845

P2093

Q37449413-2F43228B-84F7-449B-A5AD-0879B9753107

Q37449413-36C98867-F413-4283-A015-10F6FA8479D0

Q37449413-4EF065B3-68F7-4963-854E-519D89581154

Q37449413-55EBAF72-04A0-4C98-9221-695CD5C41337

Q37449413-9D6F3CAD-2D12-43FD-892E-879FFE158419

Q37449413-A985F867-1B85-462F-8309-E64D89C02443

Q37449413-DB778DE4-81D0-4A7A-AF5F-EBB752ECA00D

Q37449413-DF1D6DC3-90DB-46F5-86BA-C7F62F8F5458

Q37449413-EFB68BB7-3215-432E-9821-9664E595E968

P2860

Q37449413-01E1E8BF-5451-4DA8-8867-50EAC322E771

Q37449413-03CE8ACC-EE63-4039-8AF1-BDAECE54DF77

Q37449413-0CC2DDDF-AB34-4A7C-9D22-D94B1FA9456D

Q37449413-0E0747CD-8AD4-473D-913A-A98B8732D163

Q37449413-169A96E0-89FF-44EB-A2F4-3A753967CC98

Q37449413-19B16A16-5AE5-4F7A-B71E-A4AB3AA95413

Q37449413-1D6CD847-D750-4548-AD25-2CB9288D12EA

Q37449413-22DD6C18-33C2-472B-A29B-A2A843069525

Q37449413-23914656-B4C4-4C54-8730-B0D5A339FCD3

Q37449413-24A2A3CF-CC21-49AE-9DA4-B22FEEC5B6F5

P304

Q37449413-A6E8C315-7AE1-4CBB-ADF5-0CCFE114489F

P31

Q37449413-F23B0FEC-8AF0-4B31-8C70-A67904763EEB

P356

Q37449413-FE548346-3DF2-43AB-888F-7032F30C1ACC

P478

Q37449413-A8A23442-A24A-4D41-A4D9-32B208DFC3CA

P50

Q37449413-190E2ACE-87FD-4BCC-928A-D656C9990D85

P577

Q37449413-C08185D8-DDAD-4E6E-99B5-97B20909C44A

P5875

Q37449413-FE91B5A8-17C9-45C4-A5C6-844586F5FE1C

P698

Q37449413-5C3B69AD-02BB-446F-B8DF-090F27C9C2B4

P932

Q37449413-E4AF7FA6-8490-486E-905B-38CD7438DE01

P356

P1433

Mediators of Inflammation

P1476

Circulating Th22 and Th9 levels in patients with acute coronary syndrome

@en

P2093

Hao Liu

http://www.w3.org/2001/XMLSchema#string

Ling Liu

http://www.w3.org/2001/XMLSchema#string

Qing-wei Ji

http://www.w3.org/2001/XMLSchema#string

Qiu-tang Zeng

http://www.w3.org/2001/XMLSchema#string

Xiang Wang

http://www.w3.org/2001/XMLSchema#string

Ying Huang

http://www.w3.org/2001/XMLSchema#string

Ying Shi

http://www.w3.org/2001/XMLSchema#string

Ying-zhong Lin

http://www.w3.org/2001/XMLSchema#string

Zheng-de Lu

http://www.w3.org/2001/XMLSchema#string

P2860

IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells

Biology of interleukin-22.

Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice.

Reactive oxygen species regulate heat-shock protein 70 via the JAK/STAT pathway.

Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques.

Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells.

Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes

The immune system in atherosclerosis.

Differentiation and recruitment of Th9 cells stimulated by pleural mesothelial cells in human Mycobacterium tuberculosis infection.

Increased frequencies of Th22 cells as well as Th17 cells in the peripheral blood of patients with ankylosing spondylitis and rheumatoid arthritis

P304

635672

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2013/635672

http://www.w3.org/2001/XMLSchema#string

P478

2013

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-12-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259877561

http://www.w3.org/2001/XMLSchema#string

P698

24453425

http://www.w3.org/2001/XMLSchema#string

P932

3884785

http://www.w3.org/2001/XMLSchema#string